TEgment dissects transposable element reactivation upon CDK9 inhibition in acute myeloid leukemia
- 1Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK
Abstract
Cyclin-dependent kinase 9 (CDK9) inhibition represents a promising therapeutic strategy in cancers that disrupts RNA polymerase II pause release and collapses oncogenic transcripts. Here, we show that CDK9 inhibition also induces widespread transposable element (TE) activation across diverse cancer types. In acute myeloid leukemia (AML), CDK9 inhibition induces rapid epigenetic reprogramming and robust TE upregulation. To dissect this non-canonical transcriptional response, we developed TEgment, a TE-centric RNA-sequencing analysis pipeline that classifies TE expression into distinct structural modalities: standalone, readthrough, protein-coding gene-embedded (5'UTR, coding exons, and 3'UTRs), lncRNA-embedded, intron-retained, and TE-initiated/terminated transcription events. Applying TEgment to CDK9-inhibited AML revealed that TEs are predominantly expressed as readthrough, 3'UTR-embedded, and lncRNA-embedded transcripts rather than autonomous units, challenging prevailing assumptions about TE reactivation. TEgment provides a versatile framework for resolving TE transcriptional modalities at locus and structural levels, enabling precise interpretation of TE-derived transcripts in cancer and other contexts.
Related
- Firing Without Wiring: How REM-like Sleep Reactivation Rebalances Excitation and Inhibition to Orthogonalize Memories
- Genome-wide association study in a maize diversity panel dissects the genetic basis of lignocellulosic recalcitrance
- Transposable element DNA and RNA: Drivers of gene expression, evolution, and disease
- Transposable elements and the evolutionary origins of C4 gene expression: The story of carbonic anhydrases in Flaveria.
- Landscape of transposable element polymorphism across geographically diverse samples of the grasshopper Trilophidia annulata
BibTeX
@misc{prokopov2026tegment,
title = {{TEgment dissects transposable element reactivation upon CDK9 inhibition in acute myeloid leukemia}},
author = {D. Prokopov and A. Moussa and H. Tunbak and E. Leddy and O. Deniz},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.16.752040},
url = {https://www.biorxiv.org/content/10.64898/2026.09.16.752040v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - TEgment dissects transposable element reactivation upon CDK9 inhibition in acute myeloid leukemia
AU - D. Prokopov
AU - A. Moussa
AU - H. Tunbak
AU - E. Leddy
AU - O. Deniz
PY - 2026
DA - 2026/09/16
PB - bioRxiv
DO - 10.64898/2026.09.16.752040
UR - https://www.biorxiv.org/content/10.64898/2026.09.16.752040v1
AB - Cyclin-dependent kinase 9 (CDK9) inhibition represents a promising therapeutic strategy in cancers that disrupts RNA polymerase II pause release and collapses oncogenic transcripts. Here, we show that CDK9 inhibition also induces widespread transposable element (TE) activation across diverse cancer types. In acute myeloid leukemia (AML), CDK9 inhibition induces rapid epigenetic reprogramming and robust TE upregulation. To dissect this non-canonical transcriptional response, we developed TEgment, a TE-centric RNA-sequencing analysis pipeline that classifies TE expression into distinct structural modalities: standalone, readthrough, protein-coding gene-embedded (5'UTR, coding exons, and 3'UTRs), lncRNA-embedded, intron-retained, and TE-initiated/terminated transcription events. Applying TEgment to CDK9-inhibited AML revealed that TEs are predominantly expressed as readthrough, 3'UTR-embedded, and lncRNA-embedded transcripts rather than autonomous units, challenging prevailing assumptions about TE reactivation. TEgment provides a versatile framework for resolving TE transcriptional modalities at locus and structural levels, enabling precise interpretation of TE-derived transcripts in cancer and other contexts.
ER -